Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002397
Filing Date
2025-03-06
Accepted
2025-03-06 16:17:29
Documents
93
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K elev-20241231x10k.htm   iXBRL 10-K 2362430
2 EX-19 elev-20241231xex19.htm EX-19 77331
3 EX-21.1 elev-20241231xex21d1.htm EX-21.1 3730
4 EX-23.1 elev-20241231xex23d1.htm EX-23.1 3574
5 EX-31.1 elev-20241231xex31d1.htm EX-31.1 14590
6 EX-31.2 elev-20241231xex31d2.htm EX-31.2 14563
7 EX-32 elev-20241231xex32.htm EX-32 8003
8 GRAPHIC elev-20241231x10k001.jpg GRAPHIC 3735
9 GRAPHIC elev-20241231x10k002.jpg GRAPHIC 50677
10 GRAPHIC elev-20241231x10k003.jpg GRAPHIC 63806
11 GRAPHIC elev-20241231x10k004.jpg GRAPHIC 79573
  Complete submission text file 0001558370-25-002397.txt   9913967

Data Files

Seq Description Document Type Size
12 EX-101.SCH elev-20241231.xsd EX-101.SCH 59547
13 EX-101.CAL elev-20241231_cal.xml EX-101.CAL 54991
14 EX-101.DEF elev-20241231_def.xml EX-101.DEF 237146
15 EX-101.LAB elev-20241231_lab.xml EX-101.LAB 567227
16 EX-101.PRE elev-20241231_pre.xml EX-101.PRE 435732
96 EXTRACTED XBRL INSTANCE DOCUMENT elev-20241231x10k_htm.xml XML 1430504
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40523 | Film No.: 25715491
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)